Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Bolger John C, Director. Director active across 1 company, notably Fulgent Genetics, Inc.. Cumulatively, 8 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €8k. Activity tracked since 20 May 2021. The latest transaction was filed on 1 August 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
John C. Bolger is a Board Member at Fulgent Genetics, Inc. He plays a key role in the governance of the company, bringing his expertise in biotechnology and management. His involvement is essential in guiding strategic decisions.